Ameritas Investment Partners’s Crinetics Pharmaceuticals CRNX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$264K Hold
9,174
0.01% 1141
2025
Q1
$308K Hold
9,174
0.01% 1031
2024
Q4
$469K Buy
9,174
+1,291
+16% +$66K 0.02% 864
2024
Q3
$403K Buy
7,883
+260
+3% +$13.3K 0.01% 922
2024
Q2
$341K Buy
7,623
+864
+13% +$38.7K 0.01% 955
2024
Q1
$316K Hold
6,759
0.01% 1003
2023
Q4
$240K Buy
6,759
+282
+4% +$10K 0.01% 1154
2023
Q3
$193K Buy
6,477
+2,490
+62% +$74.1K 0.01% 1200
2023
Q2
$71.8K Hold
3,987
﹤0.01% 1814
2023
Q1
$64K Hold
3,987
﹤0.01% 1822
2022
Q4
$79.3K Hold
3,987
﹤0.01% 1751
2022
Q3
$78K Hold
3,987
﹤0.01% 1673
2022
Q2
$74K Buy
3,987
+425
+12% +$7.89K ﹤0.01% 1708
2022
Q1
$78K Hold
3,562
﹤0.01% 1788
2021
Q4
$101K Buy
3,562
+702
+25% +$19.9K ﹤0.01% 1675
2021
Q3
$60K Hold
2,860
﹤0.01% 2032
2021
Q2
$54K Buy
2,860
+470
+20% +$8.87K ﹤0.01% 2123
2021
Q1
$37K Hold
2,390
﹤0.01% 2254
2020
Q4
$34K Hold
2,390
﹤0.01% 2202
2020
Q3
$37K Hold
2,390
﹤0.01% 2021
2020
Q2
$42K Buy
2,390
+1,438
+151% +$25.3K ﹤0.01% 1936
2020
Q1
$14K Hold
952
﹤0.01% 2363
2019
Q4
$24K Hold
952
﹤0.01% 2314
2019
Q3
$14K Hold
952
﹤0.01% 2572
2019
Q2
$24K Buy
952
+378
+66% +$9.53K ﹤0.01% 2338
2019
Q1
$13K Hold
574
﹤0.01% 2591
2018
Q4
$17K Hold
574
﹤0.01% 2430
2018
Q3
$16K Buy
+574
New +$16K ﹤0.01% 2610